BioSig Technologies (NASDAQ:BSGM) Stock Price Down 8.9%

BioSig Technologies, Inc. (NASDAQ:BSGM) traded down 8.9% on Friday . The company traded as low as $0.35 and last traded at $0.41. 46,667 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 615,698 shares. The stock had previously closed at $0.45.

BioSig Technologies Stock Performance

The business has a 50 day moving average of $0.88 and a 200 day moving average of $1.13.

BioSig Technologies (NASDAQ:BSGM) last released its quarterly earnings results on Monday, May 20th. The company reported ($0.36) earnings per share (EPS) for the quarter. The business had revenue of $0.01 million for the quarter.

Institutional Trading of BioSig Technologies

A hedge fund recently bought a new stake in BioSig Technologies stock. Armistice Capital LLC acquired a new position in shares of BioSig Technologies, Inc. (NASDAQ:BSGM) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,600,000 shares of the company’s stock, valued at approximately $2,660,000. Armistice Capital LLC owned about 62.36% of BioSig Technologies as of its most recent SEC filing. Institutional investors own 7.16% of the company’s stock.

BioSig Technologies Company Profile

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.